
NYSE:ALL
This summary was created by AI, based on 1 opinions in the last 12 months.
Allstate (symbol: ALL-N) is being closely scrutinized by industry experts, particularly due to its intensive balance sheet and its current valuation metrics. Analysts note that the stock trades at a discount compared to financial giants like JPMorgan Chase, which may have a better competitive position in the market owing to larger size and more robust structural profitability. Furthermore, there are indications of upcoming global softness in the Property and Casualty (P&C) insurance markets, which could limit premium growth and heighten price competition within the sector. As a result, profitability among companies in this field may come under pressure, especially for those like Allstate. Given these concerns and comparisons, many experts express a preference for investing in banks over insurance companies at this time.
Increase in catastrophic losses means most insurers are suffering this year. For P&C insurers, bad news is good news, as they just raise prices. Great capital allocators. Raise dividends. Favour profits over market share, so divesting unprofitable businesses. Spectacularly well run. Free cashflow machine. Yield is 3.28%.
(Analysts’ price target is $125.32)It is the premier property casualty company in the U.S. Over the past decade it has had double digit dividend growth, huge share buybacks, great cash flow and a very disciplined approach. It is an incredible asset allocator and also cheap. Its 3 1/2% dividend could double over time. The stock is down a little due to supply chain issues which increases the costs to fix houses and cars, but these issues are temporary. An app that tracks driving habits can give the client a discount but it gives the company a strong picture of those habits.
Allstate is a American stock, trading under the symbol ALL (previously ALL-N on Stockchase) on the New York Stock Exchange (ALL). It is usually referred to as NYSE:ALL or ALL
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ALL (previously ALL-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Allstate.
Allstate was recommended as a Top Pick by Brian Madden on 2025-10-24. Read the latest stock experts ratings for Allstate.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Allstate.
Allstate is followed by 49 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-14, Allstate (ALL) stock closed at a price of $250.35.
For companies with intensive balance sheets, he sometimes values them on price to book (tells you what are you paying purely for the value of the shareholders equity).
Trades at a discount to JPM probably because JPM is better, bigger, with better structural profitability. Some stirrings in the P&C markets of upcoming global softness, so premiums won't go up as much as before. Price competition will most likely depress profitability in the sector.
He'd prefer the banks.